Literature DB >> 9416700

Lymphangioleiomyomatosis: recurrence after single lung transplantation.

I Bittmann1, T B Dose, C Müller, H Dienemann, C Vogelmeier, U Löhrs.   

Abstract

Lymphangioleiomyomatosis (LAM) is a rare disease which afflicts young women of childbearing age. Recently, it has been listed as an indication for lung transplantation. We describe a case of recurrent LAM in a 31-year-old woman occurring in the allograft of a male donor after single lung transplantation. Nonisotopic in situ hybridization shows that the smooth muscle cell proliferation is of donor origin.

Entities:  

Mesh：

Year:  1997        PMID： 9416700     DOI： 10.1016/s0046-8177(97)90233-1

Source DB:  PubMed          Journal:  Hum Pathol        ISSN： 0046-8177            Impact factor:   3.466


  17 in total

Review 1.  Rare diseases. 1. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms.

Authors:  S Johnson
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Regional Sparing in an Oligemic Lung Segment Supports Hematogenous Spread as a Pathogenic Mechanism in Lymphangioleiomyomatosis.

Authors:  Nishant Gupta; MeiLan K Han; Francis X McCormack
Journal:  Ann Am Thorac Soc       Date:  2015-08

3.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors:  T Carsillo; A Astrinidis; E P Henske
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

4.  Lung disease 35 years after aspiration of activated charcoal in combination with pulmonary lymphangioleiomyomatosis. A histological and clinicopathological study with scanning electron microscopic evaluation and element analysis.

Authors:  M Huber; W Pohl; G Reinisch; J Attems; S Pescosta; F Lintner
Journal:  Virchows Arch       Date:  2006-06-15       Impact factor: 4.064

5.  Tuberin regulates E-cadherin localization: implications in epithelial-mesenchymal transition.

Authors:  Elizabeth A Barnes; Heidi L Kenerson; Xiuyun Jiang; Raymond S Yeung
Journal:  Am J Pathol       Date:  2010-09-02       Impact factor: 4.307

6.  Recurrence of lymphangioleiomyomatosis: Nine years after a bilateral lung transplantation.

Authors:  Khawaja S Zaki; Zahra Aryan; Atul C Mehta; Olufemi Akindipe; Marie Budev
Journal:  World J Transplant       Date:  2016-03-24

Review 7.  Lymphangioleiomyomatosis and TSC2-/- cells.

Authors:  Thomas N Darling; Gustavo Pacheco-Rodriguez; Alfredo Gorio; Elena Lesma; Cheryl Walker; Joel Moss
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

8.  Clinical trials for rare lung diseases: lessons from lymphangioleiomyomatosis.

Authors:  Brent Kinder; Francis X McCormack
Journal:  Lymphat Res Biol       Date:  2010-03       Impact factor: 2.589

9.  Utility of transbronchial biopsy in the diagnosis of lymphangioleiomyomatosis.

Authors:  Riffat Meraj; Kathryn A Wikenheiser-Brokamp; Lisa R Young; Sue Byrnes; Francis X McCormack
Journal:  Front Med       Date:  2012-12-07       Impact factor: 4.592

10.  Faslodex inhibits estradiol-induced extracellular matrix dynamics and lung metastasis in a model of lymphangioleiomyomatosis.

Authors:  Chenggang Li; Xiaobo Zhou; Yang Sun; Erik Zhang; John D Mancini; Andrey Parkhitko; Tasha A Morrison; Edwin K Silverman; Elizabeth P Henske; Jane J Yu
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.